Nataliya Storozhylova is finishing her joint-doctoral degree in Nanomedicine and Pharmaceutical innovation in University of Nantes, France and University of Santiago de Compostela, Spain by May 2018. During her interdisciplinary PhD project (2013-2018), she has designed and developed a novel nanotechnology-based therapy for the treatment of rheumatoid arthritis. She is experienced in development, synthesis and screening of anti-inflammatory drugs, an in situ nanotechnology-based drug delivery systems engineering and in vivo evaluation in autoimmune diseases models. She has performed extensive trainings in translational research and bio business (Germany, France) and made an expert-internship in Charité Hospital, Berlin, Germany. Earlier her research was focused on cardiovascular diseases and preparation of lab-on-chip systems for pre-thrombotic conditions diagnostics. In 2011 she has got an annual Mykola Kravets’s Award for her scientific and practical contribution to the development of Ukraine.
Title : New potential nanotechnology-based therapy with novel Gal-3 inhibitor for the treatment of rheumatoid arthritis